The compound is named Elvitegravir (JTK-303) in Japan. Marketing outside Japan has been licensed to Gilead, under the brand name Stribild. The function is based on the inhibition of integrase strand transfer
Japan Tobacco press release, Dec. 6, 2012
Japan Tobacco applies for permission to introduce new anti-HIV drug in Japan